Labshake search
Citations for Tocris :
451 - 500 of 701 citations for 7 MethoxybenzoFuran 2 carboxylic acid since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2023Quote: ... (Optopharma Ltd.) and 20 nM for 1-Oleoyl lysophosphatidic acid sodium salt (LPA) (5 mM stock dissolved in water) (Tocris). As controls ...
-
bioRxiv - Neuroscience 2023Quote: ... one day of medium d10 (Medium d3–9 with 200 µM ascorbic acid [Sigma-Aldrich, A4403], 125 µM db-cAMP [Tocris, 1141], 2.5 µM DAPT [Tocris, 2634] ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 μM 6-Imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531; GABAA receptor antagonist, all from Tocris). The resting membrane potential was measured after whole-cell configuration was achieved ...
-
bioRxiv - Pharmacology and Toxicology 2019Quote: ... The P2Y2R antagonist AR-C118925XX (5-[[5-(2,8-Dimethyl-5H-dibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furancarboxamide) was obtained from Tocris (Abingdon, UK). Subsequent dilutions of receptor ligand and other reagents were made in Krebs-Ringer Glucose phosphate buffer (KRG ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... as well as the P2Y2R antagonist AR-C118925XX (5-[[5-(2,8-Dimethyl-5H-dibenzo[a,d]cyclohepten-5-yl)-3,4-dihydro-2-oxo-4-thioxo-1(2H)-pyrimidinyl]methyl]-N-2H-tetrazol-5-yl-2-furancarboxamide) were obtained from Tocris (Abingdon, UK). Subsequent dilutions of receptor ligand and other reagents were made in Krebs-Ringer Glucose phosphate buffer (KRG ...
-
bioRxiv - Neuroscience 2021Quote: ... Tadpoles were immobilized in 2 mM pancuronium bromide (Tocris) for 3–5 mins ...
-
bioRxiv - Neuroscience 2021Quote: ... Animals were immobilized with 2 mM pancuronium bromide (Tocris). To ensure rapid drug delivery to the optic tectum ...
-
bioRxiv - Neuroscience 2021Quote: ... tadpoles were immobilized with 2 mM pancuronium bromide (Tocris), and embedded in 1% low melting point agarose in a custom chamber with a glass coverslip window on one side through which the animal could view visual stimuli presented on an LED screen ...
-
bioRxiv - Molecular Biology 2019Quote: ... 2-methyl-ADP (Tocris, Bristol, UK # 475193-31-8), U46619 (Cayman Chemical # 56985-40-1) ...
-
bioRxiv - Developmental Biology 2019Quote: ... 1mM SC 236 (Cox-2 inhibitor) (all from Tocris) were added to the bottom chamber as indicated ...
-
bioRxiv - Immunology 2021Quote: ... and the Ca2+ ionophore A23187 (2 μM, Tocris Bioscience) at 37 ºC for 5 minutes before the addition of target cells/stimulatory beads ...
-
bioRxiv - Neuroscience 2021Quote: ... or the LIMK1/2 inhibitor SR-7826 (Tocris, Inc.) at 1 µM in 0.01% DMSO for 30 min ...
-
bioRxiv - Neuroscience 2021Quote: ... The concentration of DPNI-GABA was 2 mM (Tocris). Laser flashes were of 100 μs duration with power intensities at the surface of the slice up to 2 mW/μm2.
-
bioRxiv - Genomics 2020Quote: ... supplemented with SMAD inhibitors (DMH-1 2 μM Tocris, Cat. ...
-
bioRxiv - Neuroscience 2022Quote: ... The CB1 receptor agonist WIN55,212-2 (WIN, Tocris #1038) was applied at a concentration of 1 µM as indicated ...
-
bioRxiv - Cell Biology 2022Quote: ... or 2 μM of CytoD (22144-77-0, Tocris). Cells were imaged after 12-24 hours of treatment with VPA and Y27 ...
-
bioRxiv - Immunology 2022Quote: ... DOX (2 mg/kg, IV, TOCRIS, Cat. No. 2252), or Cremophor EL control 3 times in two weeks ...
-
bioRxiv - Neuroscience 2023Quote: ... clozapine-N-oxide (CNO, 2 mg/kg; Tocris, UK), intraperitoneally every alternate day for the duration of two weeks commencing at six weeks of age ...
-
bioRxiv - Cell Biology 2023Quote: ... followed by Anteriorization media-2 (10 μM SB431542 (Tocris) and 1 μM IWP2 (Tocris) ...
-
Formation of a giant unilocular vacuole via macropinocytosis-like process confers anoikis resistancebioRxiv - Cell Biology 2024Quote: ... Dynole 34-2 (Tocris, 4222, used at 10 μM), OctMAB (Tocris ...
-
bioRxiv - Cell Biology 2021Quote: ... B/D medium was supplemented during submerged culture with 1 nM EC23 (light-stable retinoic acid receptor agonist; Tocris, Abingdon, UK). After confluence was reached ...
-
bioRxiv - Neuroscience 2023Quote: ... 5-(4-Bromophenyl)-3-(1,2-dihydro-6-methyl-2-oxo-4-phenyl-3-quinolinyl)-4,5-dihydro-γ-oxo-1H-pyrazole-1-butanoic acid (DQP 1105, 10 μM dissolved in DMSO; Tocris Bioscience), or 6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX ...
-
bioRxiv - Neuroscience 2023Quote: ... one day of medium d10 (Medium d3–9 with 200 µM ascorbic acid [Sigma-Aldrich, A4403], 125 µM db-cAMP [Tocris, 1141] ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 µM 6-imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid hydrobromide (SR95531;GABAA receptor antagonist; all from Tocris Bioscience).
-
bioRxiv - Neuroscience 2023Quote: ... Mice were injected intraperitoneally (i.p.) with 5.0mg/kg synthetic kainic acid (KA) dissolved in 0.9% saline (#7065, Tocris Bioscience, Bristol, United Kingdom). At twenty-minute intervals ...
-
bioRxiv - Cancer Biology 2022Quote: ... the small molecule 3-[2-[(4-Fluorophenyl)methyl]imidazo[2,1-b]thiazol-6-yl]-2H-1-benzopyran-2-one (iMDK; TOCRIS Bio-techne, 9mg/kg), rapamycin (Sirolimus A8167 ...
-
bioRxiv - Cell Biology 2020Quote: ... Macrophages were treated with MLi-2 (Cat# 5756/10, Tocris) at 0.1 μM for 1 h before treatment with LLOMe where indicated ...
-
bioRxiv - Bioengineering 2022Quote: ... resuspended in E8 Flex medium with 2 μM Thiazovivin (Tocris) at 100,000 cells/mL ...
-
bioRxiv - Cell Biology 2022Quote: ... Stocks of the kinase inhibitor MLi-2 (10 mM; Tocris) were stored in DMSO at −20°C.
-
bioRxiv - Biochemistry 2020Quote: ... and plate blocked with 300 µL 2% BSA (#5217, Tocris) in 1xPBS for 1 hour at room temperature ...
-
bioRxiv - Neuroscience 2020Quote: ... GSK-2578215A (#4629) and MLi-2 (# 5756) were from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2020Quote: ... and D-2-amino-5-phosphonovalerate (APV, 25 µM, Tocris) in order to block synaptic transmission and ensure that the observed events were due to the stimulation only ...
-
bioRxiv - Neuroscience 2021Quote: ... coiled-coil containing protein kinase (ROCK1/2) Y27632 (Tocris, Inc.) at 10 µM in PBS for 1-2 hr ...
-
bioRxiv - Neuroscience 2022Quote: ... CU-T12-9 (TLR1/2 agonist; 2.5ug/dose; Tocris; 5414), CU-CPT22 (TLR antagonist ...
-
bioRxiv - Neuroscience 2020Quote: ... GABA (10 μM, Tocris, #A5835-25G, CAS: 56-12-2), bafilomycin (4 μM ...
-
bioRxiv - Cell Biology 2020Quote: ... Torin 1 (Tocris, 4247, 250 nM in DMSO, 2 hrs), Bortezomib (LC Labs B-1408 ...
-
bioRxiv - Developmental Biology 2022Quote: ... and GM6001 (Illomastat; CAS: 142880-36-2; Tocris, Bristol, UK) were used ...
-
bioRxiv - Neuroscience 2022Quote: ... 2 μM apilimod dimesylate (Tocris, ref. #7283, batch 1A/257560), 50 μM camostat mesylate (Tocris ...
-
bioRxiv - Neuroscience 2023Quote: ... 2 μl 20% Pluronic F-127 in DMSO (Tocris Biosciences), and 1 μl 0.5% Kolliphor EL (Sigma-Aldrich ...
-
bioRxiv - Neuroscience 2023Quote: ... CCK octapeptide (sulfated) (2 and 4 µg/kg, i.p., Tocris) and PYY3-36 were dissolved in a USP Grade sterile phosphate-buffered saline solution (PBS) ...
-
bioRxiv - Cell Biology 2023Quote: ... Cells were pre-treated with MLi-2 (5756/10, Tocris) at 100 nM for 2 hours and all subsequent treatments were performed in the presence of MLi-2 ...
-
bioRxiv - Biophysics 2023Quote: Stocks of the kinase inhibitors MLi-2 (10 mM; Tocris) and GZD-824 (10 mM ...
-
bioRxiv - Neuroscience 2023Quote: ... Step 2: synaptic blockers (50µm DL-AP-5 (Tocris #0105), 40µm L-AP4 (Tocris #0103) ...
-
bioRxiv - Cell Biology 2024Quote: ... EIPA (1154-25-2) was obtained from Tocris (Bristol, UK); a protease inhibitor cocktail (04,693,159,001 ...
-
bioRxiv - Biophysics 2024Quote: ... followed by supplementation with 2 µM IWP2 (Tocris, Bristol, UK) and 10 µM SB431542 for another 24 h ...
-
bioRxiv - Neuroscience 2023Quote: ... 20 L-AP4 (Alomone Labs) and 2-5 ACET (Tocris) (Park et al. ...
-
bioRxiv - Physiology 2024Quote: ... injected with 2 mg/kg acylated rat ghrelin (1465, Tocris) solubilized in PBS using an injection volume of 2 mL/kg body weight ...
-
bioRxiv - Neuroscience 2021Quote: ... The bath solution usually contained 6,7-dinitroquinoxaline-2,3-dione (DNQX, 10 µM) and D- aminophosphonovaleric acid (D-APV, 50 µM) to block ionotropic glutamate receptors (Tocris, Abingdon, United Kingdom). Patch electrodes had resistances of 4-6 MΩ when filled with KMeSO4- or CMeSO4-based internal solution (same as used in vivo) ...
-
bioRxiv - Neuroscience 2020Quote: ... co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris; 20 μM) (n=13) ...
-
bioRxiv - Neuroscience 2019Quote: ... (3S)-3-[[3-[[4-(Trifluoromethyl)benzoyl]amino]phenyl]methoxy]-L-aspartic acid (TFB-TBOA) was purchased from Tocris (Minneapolis, MN; Cat# 2532). All other chemicals were purchased from MilliporeSigma (Burlington ...